Global Sleeping Aids Market

Sleeping Aids Comprehensive Study by Type (Medication, Mattresses and Pillows, Sleep Laboratories, Sleep Apnea Devices, Others), Application (Insomnia, Restless Legs Syndrome, Sleep Apnea, Narcolepsy, Sleep Walking, Others) Players and Region - Global Market Outlook to 2026

Sleeping Aids Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 6.8%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Market Snapshot:
Sleeping aids are drugs & medical devices that are used to diagnose and treat various sleep disorders, like sleep apnea, restless legs syndrome, and insomnia. Sleep is a biological necessity which maintain metabolic homeostasis, effects memory as well as other cognitive function, and controls immune function. Absence of quality sleep leads to sleep disorders, which are due to medical issues, physical disturbances, environmental problems, as well as psychiatric disorders. These sleep disorders have adverse effect on the human health causing number of chronic diseases including diabetes, high blood pressure, arthritis, and stroke. The increasing awareness regarding sleeping aids devices around the globe drives the growth of global sleeping aids market over coming years.The research analyst at AMA estimates Sleeping Aids market to grow at a compounded annual growth rate of 6.8%

Segment Analysis
AMA Research have segmented the market of Global Sleeping Aids market by Type, Application and Region. On the basis of Type, Mattresses and Pillows are dominating the market in the year 2020 where as Medication stood as second largest market share.

On the basis of application, Insomnia segment is dominating the market in the year 2020

On the basis of geography, the market of Sleeping Aids has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2020.

Market Trend
Evolving Technologies in Sleeping Aid Devices

Market Drivers
Increasing Incidence of Sleep Related Disorders, Changing Lifestyle, Tense Work Conditions and Working in Shifts and Growing Geriatric and Obese Population

Opportunities
Untouched Markets in Developing Economies and Rising Awareness Regarding Sleep Disorders

Restraints
  • Hostile Effects of Sleep Aid Medication


In addition to the aforementioned factor, Increasing Incidence of Sleep Related Disorders is expected to propel the growth of the market over the forecast period.

The key Players profiled in the study are Pfizer Inc. (United States), Takeda Pharmaceutical Company Limited. (Japan), Teva Pharmaceutical Industries Ltd. (Israel), Natus Medical Incorporated (United States), Compumedics Limited (Australia), Merck & Company, Inc.(United States), Sanofi S.A.(France), GlaxoSmithKline Plc (United Kingdom) and Serta International (United States). A lot of United States players are profiled in the research study indicating a strong market dependence.

Report Objectives / Segmentation Covered

By Type
  • Medication
  • Mattresses and Pillows
  • Sleep Laboratories
  • Sleep Apnea Devices
  • Others
By Application
  • Insomnia
  • Restless Legs Syndrome
  • Sleep Apnea
  • Narcolepsy
  • Sleep Walking
  • Others
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Incidence of Sleep Related Disorders
      • 3.2.2. Changing Lifestyle
      • 3.2.3. Tense Work Conditions and Working in Shifts
      • 3.2.4. Growing Geriatric and Obese Population
    • 3.3. Market Challenges
      • 3.3.1. Patent Expiration
    • 3.4. Market Trends
      • 3.4.1. Evolving Technologies in Sleeping Aid Devices
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Sleeping Aids, by Type, Application and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Sleeping Aids (Value)
      • 5.2.1. Global Sleeping Aids by: Type (Value)
        • 5.2.1.1. Medication
        • 5.2.1.2. Mattresses and Pillows
        • 5.2.1.3. Sleep Laboratories
        • 5.2.1.4. Sleep Apnea Devices
        • 5.2.1.5. Others
      • 5.2.2. Global Sleeping Aids by: Application (Value)
        • 5.2.2.1. Insomnia
        • 5.2.2.2. Restless Legs Syndrome
        • 5.2.2.3. Sleep Apnea
        • 5.2.2.4. Narcolepsy
        • 5.2.2.5. Sleep Walking
        • 5.2.2.6. Others
      • 5.2.3. Global Sleeping Aids Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Sleeping Aids: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Pfizer Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Takeda Pharmaceutical Company Limited. (Japan)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Teva Pharmaceutical Industries Ltd. (Israel)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Natus Medical Incorporated (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Compumedics Limited (Australia)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Merck & Company, Inc.(United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Sanofi S.A.(France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. GlaxoSmithKline Plc (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Serta International (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Sleeping Aids Sale, by Type, Application and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Sleeping Aids (Value)
      • 7.2.1. Global Sleeping Aids by: Type (Value)
        • 7.2.1.1. Medication
        • 7.2.1.2. Mattresses and Pillows
        • 7.2.1.3. Sleep Laboratories
        • 7.2.1.4. Sleep Apnea Devices
        • 7.2.1.5. Others
      • 7.2.2. Global Sleeping Aids by: Application (Value)
        • 7.2.2.1. Insomnia
        • 7.2.2.2. Restless Legs Syndrome
        • 7.2.2.3. Sleep Apnea
        • 7.2.2.4. Narcolepsy
        • 7.2.2.5. Sleep Walking
        • 7.2.2.6. Others
      • 7.2.3. Global Sleeping Aids Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Sleeping Aids: by Type(USD Billion)
  • Table 2. Sleeping Aids Medication , by Region USD Billion (2015-2020)
  • Table 3. Sleeping Aids Mattresses and Pillows , by Region USD Billion (2015-2020)
  • Table 4. Sleeping Aids Sleep Laboratories , by Region USD Billion (2015-2020)
  • Table 5. Sleeping Aids Sleep Apnea Devices , by Region USD Billion (2015-2020)
  • Table 6. Sleeping Aids Others , by Region USD Billion (2015-2020)
  • Table 7. Sleeping Aids: by Application(USD Billion)
  • Table 8. Sleeping Aids Insomnia , by Region USD Billion (2015-2020)
  • Table 9. Sleeping Aids Restless Legs Syndrome , by Region USD Billion (2015-2020)
  • Table 10. Sleeping Aids Sleep Apnea , by Region USD Billion (2015-2020)
  • Table 11. Sleeping Aids Narcolepsy , by Region USD Billion (2015-2020)
  • Table 12. Sleeping Aids Sleep Walking , by Region USD Billion (2015-2020)
  • Table 13. Sleeping Aids Others , by Region USD Billion (2015-2020)
  • Table 14. South America Sleeping Aids, by Country USD Billion (2015-2020)
  • Table 15. South America Sleeping Aids, by Type USD Billion (2015-2020)
  • Table 16. South America Sleeping Aids, by Application USD Billion (2015-2020)
  • Table 17. Brazil Sleeping Aids, by Type USD Billion (2015-2020)
  • Table 18. Brazil Sleeping Aids, by Application USD Billion (2015-2020)
  • Table 19. Argentina Sleeping Aids, by Type USD Billion (2015-2020)
  • Table 20. Argentina Sleeping Aids, by Application USD Billion (2015-2020)
  • Table 21. Rest of South America Sleeping Aids, by Type USD Billion (2015-2020)
  • Table 22. Rest of South America Sleeping Aids, by Application USD Billion (2015-2020)
  • Table 23. Asia Pacific Sleeping Aids, by Country USD Billion (2015-2020)
  • Table 24. Asia Pacific Sleeping Aids, by Type USD Billion (2015-2020)
  • Table 25. Asia Pacific Sleeping Aids, by Application USD Billion (2015-2020)
  • Table 26. China Sleeping Aids, by Type USD Billion (2015-2020)
  • Table 27. China Sleeping Aids, by Application USD Billion (2015-2020)
  • Table 28. Japan Sleeping Aids, by Type USD Billion (2015-2020)
  • Table 29. Japan Sleeping Aids, by Application USD Billion (2015-2020)
  • Table 30. India Sleeping Aids, by Type USD Billion (2015-2020)
  • Table 31. India Sleeping Aids, by Application USD Billion (2015-2020)
  • Table 32. South Korea Sleeping Aids, by Type USD Billion (2015-2020)
  • Table 33. South Korea Sleeping Aids, by Application USD Billion (2015-2020)
  • Table 34. Taiwan Sleeping Aids, by Type USD Billion (2015-2020)
  • Table 35. Taiwan Sleeping Aids, by Application USD Billion (2015-2020)
  • Table 36. Australia Sleeping Aids, by Type USD Billion (2015-2020)
  • Table 37. Australia Sleeping Aids, by Application USD Billion (2015-2020)
  • Table 38. Rest of Asia-Pacific Sleeping Aids, by Type USD Billion (2015-2020)
  • Table 39. Rest of Asia-Pacific Sleeping Aids, by Application USD Billion (2015-2020)
  • Table 40. Europe Sleeping Aids, by Country USD Billion (2015-2020)
  • Table 41. Europe Sleeping Aids, by Type USD Billion (2015-2020)
  • Table 42. Europe Sleeping Aids, by Application USD Billion (2015-2020)
  • Table 43. Germany Sleeping Aids, by Type USD Billion (2015-2020)
  • Table 44. Germany Sleeping Aids, by Application USD Billion (2015-2020)
  • Table 45. France Sleeping Aids, by Type USD Billion (2015-2020)
  • Table 46. France Sleeping Aids, by Application USD Billion (2015-2020)
  • Table 47. Italy Sleeping Aids, by Type USD Billion (2015-2020)
  • Table 48. Italy Sleeping Aids, by Application USD Billion (2015-2020)
  • Table 49. United Kingdom Sleeping Aids, by Type USD Billion (2015-2020)
  • Table 50. United Kingdom Sleeping Aids, by Application USD Billion (2015-2020)
  • Table 51. Netherlands Sleeping Aids, by Type USD Billion (2015-2020)
  • Table 52. Netherlands Sleeping Aids, by Application USD Billion (2015-2020)
  • Table 53. Rest of Europe Sleeping Aids, by Type USD Billion (2015-2020)
  • Table 54. Rest of Europe Sleeping Aids, by Application USD Billion (2015-2020)
  • Table 55. MEA Sleeping Aids, by Country USD Billion (2015-2020)
  • Table 56. MEA Sleeping Aids, by Type USD Billion (2015-2020)
  • Table 57. MEA Sleeping Aids, by Application USD Billion (2015-2020)
  • Table 58. Middle East Sleeping Aids, by Type USD Billion (2015-2020)
  • Table 59. Middle East Sleeping Aids, by Application USD Billion (2015-2020)
  • Table 60. Africa Sleeping Aids, by Type USD Billion (2015-2020)
  • Table 61. Africa Sleeping Aids, by Application USD Billion (2015-2020)
  • Table 62. North America Sleeping Aids, by Country USD Billion (2015-2020)
  • Table 63. North America Sleeping Aids, by Type USD Billion (2015-2020)
  • Table 64. North America Sleeping Aids, by Application USD Billion (2015-2020)
  • Table 65. United States Sleeping Aids, by Type USD Billion (2015-2020)
  • Table 66. United States Sleeping Aids, by Application USD Billion (2015-2020)
  • Table 67. Canada Sleeping Aids, by Type USD Billion (2015-2020)
  • Table 68. Canada Sleeping Aids, by Application USD Billion (2015-2020)
  • Table 69. Mexico Sleeping Aids, by Type USD Billion (2015-2020)
  • Table 70. Mexico Sleeping Aids, by Application USD Billion (2015-2020)
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Company Basic Information, Sales Area and Its Competitors
  • Table 79. Company Basic Information, Sales Area and Its Competitors
  • Table 80. Sleeping Aids: by Type(USD Billion)
  • Table 81. Sleeping Aids Medication , by Region USD Billion (2021-2026)
  • Table 82. Sleeping Aids Mattresses and Pillows , by Region USD Billion (2021-2026)
  • Table 83. Sleeping Aids Sleep Laboratories , by Region USD Billion (2021-2026)
  • Table 84. Sleeping Aids Sleep Apnea Devices , by Region USD Billion (2021-2026)
  • Table 85. Sleeping Aids Others , by Region USD Billion (2021-2026)
  • Table 86. Sleeping Aids: by Application(USD Billion)
  • Table 87. Sleeping Aids Insomnia , by Region USD Billion (2021-2026)
  • Table 88. Sleeping Aids Restless Legs Syndrome , by Region USD Billion (2021-2026)
  • Table 89. Sleeping Aids Sleep Apnea , by Region USD Billion (2021-2026)
  • Table 90. Sleeping Aids Narcolepsy , by Region USD Billion (2021-2026)
  • Table 91. Sleeping Aids Sleep Walking , by Region USD Billion (2021-2026)
  • Table 92. Sleeping Aids Others , by Region USD Billion (2021-2026)
  • Table 93. South America Sleeping Aids, by Country USD Billion (2021-2026)
  • Table 94. South America Sleeping Aids, by Type USD Billion (2021-2026)
  • Table 95. South America Sleeping Aids, by Application USD Billion (2021-2026)
  • Table 96. Brazil Sleeping Aids, by Type USD Billion (2021-2026)
  • Table 97. Brazil Sleeping Aids, by Application USD Billion (2021-2026)
  • Table 98. Argentina Sleeping Aids, by Type USD Billion (2021-2026)
  • Table 99. Argentina Sleeping Aids, by Application USD Billion (2021-2026)
  • Table 100. Rest of South America Sleeping Aids, by Type USD Billion (2021-2026)
  • Table 101. Rest of South America Sleeping Aids, by Application USD Billion (2021-2026)
  • Table 102. Asia Pacific Sleeping Aids, by Country USD Billion (2021-2026)
  • Table 103. Asia Pacific Sleeping Aids, by Type USD Billion (2021-2026)
  • Table 104. Asia Pacific Sleeping Aids, by Application USD Billion (2021-2026)
  • Table 105. China Sleeping Aids, by Type USD Billion (2021-2026)
  • Table 106. China Sleeping Aids, by Application USD Billion (2021-2026)
  • Table 107. Japan Sleeping Aids, by Type USD Billion (2021-2026)
  • Table 108. Japan Sleeping Aids, by Application USD Billion (2021-2026)
  • Table 109. India Sleeping Aids, by Type USD Billion (2021-2026)
  • Table 110. India Sleeping Aids, by Application USD Billion (2021-2026)
  • Table 111. South Korea Sleeping Aids, by Type USD Billion (2021-2026)
  • Table 112. South Korea Sleeping Aids, by Application USD Billion (2021-2026)
  • Table 113. Taiwan Sleeping Aids, by Type USD Billion (2021-2026)
  • Table 114. Taiwan Sleeping Aids, by Application USD Billion (2021-2026)
  • Table 115. Australia Sleeping Aids, by Type USD Billion (2021-2026)
  • Table 116. Australia Sleeping Aids, by Application USD Billion (2021-2026)
  • Table 117. Rest of Asia-Pacific Sleeping Aids, by Type USD Billion (2021-2026)
  • Table 118. Rest of Asia-Pacific Sleeping Aids, by Application USD Billion (2021-2026)
  • Table 119. Europe Sleeping Aids, by Country USD Billion (2021-2026)
  • Table 120. Europe Sleeping Aids, by Type USD Billion (2021-2026)
  • Table 121. Europe Sleeping Aids, by Application USD Billion (2021-2026)
  • Table 122. Germany Sleeping Aids, by Type USD Billion (2021-2026)
  • Table 123. Germany Sleeping Aids, by Application USD Billion (2021-2026)
  • Table 124. France Sleeping Aids, by Type USD Billion (2021-2026)
  • Table 125. France Sleeping Aids, by Application USD Billion (2021-2026)
  • Table 126. Italy Sleeping Aids, by Type USD Billion (2021-2026)
  • Table 127. Italy Sleeping Aids, by Application USD Billion (2021-2026)
  • Table 128. United Kingdom Sleeping Aids, by Type USD Billion (2021-2026)
  • Table 129. United Kingdom Sleeping Aids, by Application USD Billion (2021-2026)
  • Table 130. Netherlands Sleeping Aids, by Type USD Billion (2021-2026)
  • Table 131. Netherlands Sleeping Aids, by Application USD Billion (2021-2026)
  • Table 132. Rest of Europe Sleeping Aids, by Type USD Billion (2021-2026)
  • Table 133. Rest of Europe Sleeping Aids, by Application USD Billion (2021-2026)
  • Table 134. MEA Sleeping Aids, by Country USD Billion (2021-2026)
  • Table 135. MEA Sleeping Aids, by Type USD Billion (2021-2026)
  • Table 136. MEA Sleeping Aids, by Application USD Billion (2021-2026)
  • Table 137. Middle East Sleeping Aids, by Type USD Billion (2021-2026)
  • Table 138. Middle East Sleeping Aids, by Application USD Billion (2021-2026)
  • Table 139. Africa Sleeping Aids, by Type USD Billion (2021-2026)
  • Table 140. Africa Sleeping Aids, by Application USD Billion (2021-2026)
  • Table 141. North America Sleeping Aids, by Country USD Billion (2021-2026)
  • Table 142. North America Sleeping Aids, by Type USD Billion (2021-2026)
  • Table 143. North America Sleeping Aids, by Application USD Billion (2021-2026)
  • Table 144. United States Sleeping Aids, by Type USD Billion (2021-2026)
  • Table 145. United States Sleeping Aids, by Application USD Billion (2021-2026)
  • Table 146. Canada Sleeping Aids, by Type USD Billion (2021-2026)
  • Table 147. Canada Sleeping Aids, by Application USD Billion (2021-2026)
  • Table 148. Mexico Sleeping Aids, by Type USD Billion (2021-2026)
  • Table 149. Mexico Sleeping Aids, by Application USD Billion (2021-2026)
  • Table 150. Research Programs/Design for This Report
  • Table 151. Key Data Information from Secondary Sources
  • Table 152. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Sleeping Aids: by Type USD Billion (2015-2020)
  • Figure 5. Global Sleeping Aids: by Application USD Billion (2015-2020)
  • Figure 6. South America Sleeping Aids Share (%), by Country
  • Figure 7. Asia Pacific Sleeping Aids Share (%), by Country
  • Figure 8. Europe Sleeping Aids Share (%), by Country
  • Figure 9. MEA Sleeping Aids Share (%), by Country
  • Figure 10. North America Sleeping Aids Share (%), by Country
  • Figure 11. Global Sleeping Aids share by Players 2020 (%)
  • Figure 12. Global Sleeping Aids share by Players (Top 3) 2020(%)
  • Figure 13. Global Sleeping Aids share by Players (Top 5) 2020(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 16. Pfizer Inc. (United States) Revenue: by Geography 2020
  • Figure 17. Takeda Pharmaceutical Company Limited. (Japan) Revenue, Net Income and Gross profit
  • Figure 18. Takeda Pharmaceutical Company Limited. (Japan) Revenue: by Geography 2020
  • Figure 19. Teva Pharmaceutical Industries Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 20. Teva Pharmaceutical Industries Ltd. (Israel) Revenue: by Geography 2020
  • Figure 21. Natus Medical Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 22. Natus Medical Incorporated (United States) Revenue: by Geography 2020
  • Figure 23. Compumedics Limited (Australia) Revenue, Net Income and Gross profit
  • Figure 24. Compumedics Limited (Australia) Revenue: by Geography 2020
  • Figure 25. Merck & Company, Inc.(United States) Revenue, Net Income and Gross profit
  • Figure 26. Merck & Company, Inc.(United States) Revenue: by Geography 2020
  • Figure 27. Sanofi S.A.(France) Revenue, Net Income and Gross profit
  • Figure 28. Sanofi S.A.(France) Revenue: by Geography 2020
  • Figure 29. GlaxoSmithKline Plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 30. GlaxoSmithKline Plc (United Kingdom) Revenue: by Geography 2020
  • Figure 31. Serta International (United States) Revenue, Net Income and Gross profit
  • Figure 32. Serta International (United States) Revenue: by Geography 2020
  • Figure 33. Global Sleeping Aids: by Type USD Billion (2021-2026)
  • Figure 34. Global Sleeping Aids: by Application USD Billion (2021-2026)
  • Figure 35. South America Sleeping Aids Share (%), by Country
  • Figure 36. Asia Pacific Sleeping Aids Share (%), by Country
  • Figure 37. Europe Sleeping Aids Share (%), by Country
  • Figure 38. MEA Sleeping Aids Share (%), by Country
  • Figure 39. North America Sleeping Aids Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Pfizer Inc. (United States)
  • Takeda Pharmaceutical Company Limited. (Japan)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Natus Medical Incorporated (United States)
  • Compumedics Limited (Australia)
  • Merck & Company, Inc.(United States)
  • Sanofi S.A.(France)
  • GlaxoSmithKline Plc (United Kingdom)
  • Serta International (United States)
Additional players considered in the study are as follows:
Cadwell Industries, Inc.(United States) , Koninklijke Philips N.V. (The Netherlands)
Select User Access Type

Key Highlights of Report


Apr 2021 221 Pages 72 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Sleeping Aids Market Quantitative research analysis
Global Sleeping Aids Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Sleeping Aids Market Report?

Have a Query? Click Here

Other Related Reports

Western Blotting Comprehensive Study by Type (Consumables {Reagents, Kits and Other}, Instruments {Blotting Systems (Wet and Semi-Dry) and Imagers (Chemiluminescent, Fluorescent and Other)}), Applica...
$ 3650
Orthopedic Shoes Comprehensive Study by Type (Flatfoot Orthopedic Shoes, Cavus Orthopedic Shoes, Calcaneal Spur Orthopedic Shoes, Varus and Valgus Orthopedic Shoes, Other), Application (Children, Adu...
$ 3450
Safety Syringes Comprehensive Study by Type (Retractable {Automatic, Manual}, Non Retractable {Sliding Needle , Sheathing Tube , Hinged Needle}), Application (Hospitals, Home Care), Therapy (Insulin,...
$ 3450
Prostate Cancer Comprehensive Study by Type (Hormone sensitive prostate cancer, Hormone refractory prostate cancer), Application (Chemotherapy, Hormonal Therapy, Targeted Therapy, Immunotherapy), The...
$ 3450
Indoor Cycles Comprehensive Study by Type (Upright Indoor Cycles, Recumbent Indoor Cycles), Application (In-House, Gym, Playground, Other), Age Group (Above 35, 20-35, Below 20), End User (Male, Fema...
$ 3500
Home Infusion Therapy Comprehensive Study by Type (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors), Application (Anti-infective, Hydration Therapy, Chemotherapy, Enteral Nutriti...
$ 3450